510(k) · Cleared
ClearedLamitrode Leads
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Advanced Neuromodulation Systems · GZB Stimulator, Spinal-Cord, Implanted (Pain Relief)
Cleared on Jun 3, 1999 as substantially equivalent to K853643 (Neuromed, Inc., 1985) and 5 other predicates after a 107-day review. Its family tree reaches back 2 generations to 1981.
- Decided
- Jun 3, 1999
- Review
- 107 days
- Class
- Class II
- Product code
- GZB
- Recalls
- None
- Predicates
- 6
Its longest line of descent runs back 2 generations to K810182 (1981). 8 ancestors in all. No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K810182 | Programmable Spinal Coral Stim. System | Electronic Diagnostics, Inc. | 1981 | — |
| −1 | K960728 | One Step Connect Leads (Quattrode, Octrode, Cervitrode) | Neuromed, Inc. | 1996 | — |
| 0 (this device) | K990469 | Lamitrode Leads | Advanced Neuromodulation Systems | 1999 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1981 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1989 | 1 | 0 |
| 1991 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GZB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GZB device
- #1 K221376 Nalu Neurostimulation Systemscore 8.9 · 9 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K853643 | Multistim Laminectomy ElectrodeSummary page 2…or Pain Relief Predicate Device: Advanced Neuromodulation Systems, Inc.,., currently markets spinal cord stimulator systems with Silicone lead insulators under 510(k) # K853643 and K905255 and K960728. Device Description: Advanced Neuromodulation Systems, Inc.’s Lamitrode Leads are implantable devices co… | 1985 |
| * | K905255 | Neuromed Model 1992 LS Lamitrode LeadSummary page 2…ef Predicate Device: Advanced Neuromodulation Systems, Inc.,., currently markets spinal cord stimulator systems with Silicone lead insulators under 510(k) # K853643 and K905255 and K960728. Device Description: Advanced Neuromodulation Systems, Inc.’s Lamitrode Leads are implantable devices consisting of… | 1991 |
| * | K960728 | One Step Connect Leads (Quattrode, Octrode, Cervitrode)Summary page 2…e Device: Advanced Neuromodulation Systems, Inc.,., currently markets spinal cord stimulator systems with Silicone lead insulators under 510(k) # K853643 and K905255 and K960728. Device Description: Advanced Neuromodulation Systems, Inc.’s Lamitrode Leads are implantable devices consisting of spaced elect… | 1996 |
| * | K884948 | Model 3587A Resume Epidural LeadSummary page 3…EXAS 75002 / 972 390-9800 / FAX: 972 390-2881 HANS Page 3 of 3 ANS Predicate Device 510(k) K853643, K905255, K960728 Medtronic Predicate Device 510(k} K884948, K811655, and K905407 ANS Modified Device K# Under Review Intended Use: Stimulation of spinal cord for treatment of chronic pa… | 1989 |
| * | K811655 | Myelostat Dorsal Cord StimulatorSummary page 3…2 / 972 390-9800 / FAX: 972 390-2881 HANS Page 3 of 3 ANS Predicate Device 510(k) K853643, K905255, K960728 Medtronic Predicate Device 510(k} K884948, K811655, and K905407 ANS Modified Device K# Under Review Intended Use: Stimulation of spinal cord for treatment of chronic pain of the… | 1981 |
| * | K905407 | Model 3487A Pisces-Quad,3587A Resume,3586 ResumeSummary page 3…800 / FAX: 972 390-2881 HANS Page 3 of 3 ANS Predicate Device 510(k) K853643, K905255, K960728 Medtronic Predicate Device 510(k} K884948, K811655, and K905407 ANS Modified Device K# Under Review Intended Use: Stimulation of spinal cord for treatment of chronic pain of the trunk and li… | 1991 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 18 years and passes through 3 companies; a new generation was cleared every 15.1 years on median.
- None of the 8 ancestors has a recall.
How does its category compare?
All GZB devicesGZB Stimulator, Spinal-Cord, Implanted (Pain Relief): FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GZB
1in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · GZB
149in 2019
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GZB
1in 2010
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GZB
313in 2025
MAUDE reports naming product code GZB, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 201 |
| 2008 | 1 | — | 1 | 68 |
| 2009 | 3 | 62 | 0 | 59 |
| 2010 | 1 | — | 1 | 157 |
| 2011 | 4 | 67 | 0 | 471 |
| 2012 | 2 | — | 0 | 1,090 |
| 2013 | 2 | — | 0 | 4,428 |
| 2014 | 2 | — | 0 | 10,849 |
| 2015 | 2 | — | 0 | 7,507 |
| 2016 | 2 | — | 0 | 4,556 |
| 2017 | 2 | — | 0 | 5,511 |
| 2018 | 1 | — | 0 | 5,244 |
| 2019 | 4 | 149 | 0 | 643 |
| 2020 | 2 | — | 0 | 466 |
| 2021 | 1 | — | 0 | 332 |
| 2022 | 1 | — | 0 | 209 |
| 2023 | 0 | — | 0 | 236 |
| 2024 | 1 | — | 0 | 318 |
| 2025 | 0 | — | 0 | 313 |
| 2026 | 0 | — | 1 | — |
What is it indicated for?
Advanced Neuromodulation Systems Lamitrode Spinal Cord Stimulation Leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach and is intended to be used with Advanced Neuromodulation Systems extensions and/or receivers, transmitters, and antennae. The proposed device modification does not affect the original intended use of the legally marketed device.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K990469 · printed Nov 4, 2026
Cite this page
510(k) Report. “K990469: Lamitrode Leads.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K990469
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026